Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Acetoin)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST002316 AN003783 Differential requirements for mitochondrial electron transport chain components in the adult murine liver - Untargeted Metabolomics (qTOF) Liver Mouse Metabolic syndrome The University of Texas Southwestern Medical Center at Dallas area
ST002113 AN003460 Metabolomic analyses redefine the biological classification of pancreatic cancer: From clinical stage to metabolic subtype Blood Human Cancer Xiamen University area under peak
ST002697 AN004371 Employing Hindlimb Unloading Model for The Identification of Serum Biomarkers Associated with Cardiovascular and Skeletal Muscle Deconditioning. Blood Mouse Musculoskeletal system disease Sharjah Institute for Medical Research AU
ST002731 AN004428 Untargeted Multi-Omics of LNCaP Cell-line Treated with Novel DNA Minor Groove Binder and /or Doxorubicin Using Mass-Spectrometry LNCaP cells Human Cancer Sharjah Institute for Medical Research AU
ST002755 AN004472 Metabolomics Profiling of the Antiproliferative, Anti-migratory and Anti-invasive Potential of Amlodipine in Lung Cancer Cells Lung Human Cancer Sharjah Institute for Medical Research AU
ST000148 AN000235 A549 13C-labeled Cell Study Epithelial cells Human Cancer University of Kentucky normalized corrected peak area
ST000016 AN000033 NPM-ALK metabolic regulation Lymphoma cells Human University of Michigan Peak area
ST000142 AN000225 H1299 13C-labeled Cell Study Lung Human Cancer University of Kentucky Peak area
ST001218 AN002031 Wild type versus TRACK Mice on regular chow and Vitamin A deprived diet Kidney Mouse Cancer weill cornell medicine Peak area
ST001265 AN002102 Comparative metabolomics of MCF-7 breast cancer cells using different extraction solvents assessed by mass spectroscopy Breast cancer cells Human Cancer Sharjah Institute for Medical Research Peak area
ST002876 AN004713 High Level Expression of NSD2 Creates a Metabolic Dependency in Multiple Myeloma B-cells Human Cancer University of Florida Peak area
ST000421 AN000663 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000421 AN000664 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000421 AN000665 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000422 AN000667 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000422 AN000668 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000422 AN000669 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000045 AN000075 Plasma metabolomics: Comparison of non-diabetic controls with T1D patients Blood Human Mayo Clinic Raw MS Intensities
ST000046 AN000076 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000046 AN000077 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000046 AN000078 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000046 AN000079 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000047 AN000080 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) Cerebrospinal fluid Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000047 AN000081 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) Cerebrospinal fluid Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000047 AN000082 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) Cerebrospinal fluid Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000047 AN000083 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) Cerebrospinal fluid Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST002231 AN003641 Metabolomics Analysis of HOG-EV and HOG-R132H Cells with and without BAY 2402234 Treatment Cultured cells Human Cancer UT Southwestern Medical Center TIC-Corrected Peak Area
ST000588 AN000903 Metabolomics of Saliva in Decompensated Heart Failure Saliva Human Heart disease Mayo Clinic uM
ST002082 AN003397 Predicting dying: a study of the metabolic changes and the dying process in patients with lung cancer Urine Human Cancer University of Liverpool Institute of Life Course & Medical Sciences Values are raw peak area
  logo